Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
90.25%
-
Total 13F principal
-
$379,145,801
-
Principal change
-
-$29,563,505
-
Total reported market value
-
$344,249,220
-
Number of holders
-
47
-
Value change
-
-$28,980,281
-
Number of buys
-
13
-
Number of sells
-
20
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q4 2018
As of 31 Dec 2018,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
47 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$379,145,801
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, OAKTREE CAPITAL MANAGEMENT LP, Southpaw Asset Management LP, WELLS FARGO & COMPANY/MN, INCOME RESEARCH & MANAGEMENT, AXA, STATE STREET CORP, Capital World Investors, and CREDIT SUISSE AG/.
This page lists
47
institutional bondholders reporting positions
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.